Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Equity Average (2016 - 2025)

Xtant Medical Holdings has reported Equity Average over the past 15 years, most recently at $50.7 million for Q4 2025.

  • Quarterly Equity Average rose 14.26% to $50.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.7 million through Dec 2025, up 14.26% year-over-year, with the annual reading at $47.0 million for FY2025, 0.42% changed from the prior year.
  • Equity Average was $50.7 million for Q4 2025 at Xtant Medical Holdings, up from $49.4 million in the prior quarter.
  • Over five years, Equity Average peaked at $53.0 million in Q4 2023 and troughed at $23.9 million in Q1 2021.
  • The 5-year median for Equity Average is $38.2 million (2021), against an average of $39.1 million.
  • Year-over-year, Equity Average soared 5823.51% in 2021 and then dropped 16.36% in 2024.
  • A 5-year view of Equity Average shows it stood at $31.8 million in 2021, then grew by 5.39% to $33.5 million in 2022, then soared by 58.39% to $53.0 million in 2023, then dropped by 16.36% to $44.3 million in 2024, then increased by 14.26% to $50.7 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Equity Average are $50.7 million (Q4 2025), $49.4 million (Q3 2025), and $46.2 million (Q2 2025).